SuperworthLifecore Biomedical shares outstanding LFCR
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 37.6M
- On a year earlier
- +9.4%
- more shares
Lifecore Biomedical had 37.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 9.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 37M | +21% |
| FY2024 | 30.5M | +1% |
| FY2023 | 30.3M | +3% |
| FY2022 | 29.5M | +1% |
| FY2021 | 29.3M | +1% |
| FY2020 | 29.2M | +1% |
| FY2019 | 29M | +4% |
| FY2018 | 28M | +1% |
| FY2017 | 27.8M | +3% |
| FY2016 | 27.1M | −1% |
| FY2015 | 27.4M | +1% |
| FY2014 | 27.2M | +1% |
| FY2013 | 27M | +4% |
| FY2012 | 25.9M | −2% |
| FY2011 | 26.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 37.6M | +9% | |
| Q1 FY26 | 37.5M | +21% | |
| Q2 FY25 | 37.4M | +3% | |
| Q4 FY25 | 37M | +21% | |
| Q3 FY25 | 37M | +1% | |
| Q2 FY25 | 34.4M | −6% | |
| Q1 FY25 | 30.9M | +1% | |
| Q4 FY24 | 30.5M | +1% | |
| Q3 FY24 | 36.6M | +21% | |
| Q2 FY24 | 36.4M | +23% | |
| Q1 FY24 | 30.4M | +3% | |
| Q4 FY23 | 30.3M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lifecore Biomedical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.